Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting the anterior superior iliac spine yields significantly longer bone marrow cores.
Reed L, Attarian S, Pendurti G, Singh AP, Budhathoki A, Abi-Aad S, Shah UA, Kim S, Bachiashvili K, Moon JY, Kim M, Elrafei T, Alexis K, Strakhan M, Li W, Friedman E. Reed L, et al. J Clin Pathol. 2018 Feb;71(2):172-173. doi: 10.1136/jclinpath-2017-204686. Epub 2017 Aug 26. J Clin Pathol. 2018. PMID: 28844037 Clinical Trial.
Visualization of the bone marrow biopsy needle track.
Attarian S, Reed L, Singh S, Shestopalov A, Singh AP, Budhathoki A, Abi-Aad S, Shah UA, Kim S, Bachiashvili K, Elrafei T, Li W, Yee C, Friedman EW. Attarian S, et al. Among authors: friedman ew. Am J Hematol. 2018 Mar;93(3):E60-E61. doi: 10.1002/ajh.24985. Epub 2017 Dec 6. Am J Hematol. 2018. PMID: 29168229 Free article. No abstract available.
Ruxolitinib withdrawal syndrome leading to tumor lysis.
Dai T, Friedman EW, Barta SK. Dai T, et al. Among authors: friedman ew. J Clin Oncol. 2013 Oct 10;31(29):e430-2. doi: 10.1200/JCO.2012.47.6473. Epub 2013 Jun 10. J Clin Oncol. 2013. PMID: 23752116 No abstract available.
Analysis of chronic myelogenous leukemia in an underserved, inner-city cohort shows a significant five year overall survival that is not affected by choice of tyrosine kinase inhibitor.
Assal A, Dong B, Khan H, Medavarapu R, Shastri A, Pradhan K, Friedman E, Mantzaris I, Janakiram M, Battini R, Kornblum N, Yu Y, Verma A, Braunschweig I, Derman O. Assal A, et al. Leuk Lymphoma. 2016 Oct;57(10):2452-5. doi: 10.3109/10428194.2016.1142087. Epub 2016 Feb 17. Leuk Lymphoma. 2016. PMID: 26886689 No abstract available.
Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase.
Zhou L, McMahon C, Bhagat T, Alencar C, Yu Y, Fazzari M, Sohal D, Heuck C, Gundabolu K, Ng C, Mo Y, Shen W, Wickrema A, Kong G, Friedman E, Sokol L, Mantzaris I, Pellagatti A, Boultwood J, Platanias LC, Steidl U, Yan L, Yingling JM, Lahn MM, List A, Bitzer M, Verma A. Zhou L, et al. Cancer Res. 2011 Feb 1;71(3):955-63. doi: 10.1158/0008-5472.CAN-10-2933. Epub 2010 Dec 28. Cancer Res. 2011. PMID: 21189329 Free PMC article.
63 results